Characterization of minute adenocarcinomas of prostate at radical prostatectomy

Franks, 1954, Latent carcinoma of the prostate, J Pathol Bacteriol, 68, 608, 10.1002/path.1700680233 Sakr, 1993, The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients, J Urol, 150, 379, 10.1016/S0022-5347(17)35487-3 Stamey, 1993, Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer, Cancer, 71, 933, 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.271.5.368 Dugan, 1996, The definition and preoperative prediction of clinically insignificant prostate cancer, JAMA, 275, 288, 10.1001/jama.275.4.288 Goldstein, 1995, Minimal or no cancer in radical prostatectomy specimens: report of 13 cases of the “vanishing cancer phenomenon.”, Am J Surg Pathol, 19, 1002, 10.1097/00000478-199509000-00003 DiGiuseppe, 1997, Increasing incidence of minimal residual cancer in radical prostatectomy specimens, Am J Surg Pathol, 21, 174, 10.1097/00000478-199702000-00006 Bastacky, 1991, Needle biopsy associated tumor tracking of adenocarcinoma of the prostate, J Urol, 145, 1003, 10.1016/S0022-5347(17)38513-0 Wise, 2002, Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens, Urology, 60, 264, 10.1016/S0090-4295(02)01728-4 Bastacky, 1995, Pathological features of hereditary prostate cancer, J Urol, 153, 987, 10.1016/S0022-5347(01)67619-5 Beckner, 1985, Endometrial carcinoma: nontumor factors in prognosis, Int J Gynecol Pathol, 4, 131, 10.1097/00004347-198506000-00005 McNaughton Collins, 1997, Early detection of prostate cancer: serendipity strikes again, JAMA, 278, 1516, 10.1001/jama.278.18.1516 Stamey, 2002, Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml, J Urol, 167, 103, 10.1016/S0022-5347(05)65392-X Allan, 2003, Correlation of minute (0.5 mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density, J Urol, 170, 370, 10.1097/01.ju.0000074747.72993.cb